CoChat
Sign Up
Cited by 233

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

IL-6 Improves Energy and Glucose Homeostasis in Obesity via Enhanced Central IL-6 trans-Signaling

Timper, Katharina, Denson, Jesse Lee, Steculorum, Sophie Marie, Heilinger, Christian, Engström-Ruud, Linda, Wunderlich, Claudia Maria, Rose-John, Stefan, Wunderlich, F. Thomas, Brüning, Jens Claus·2017·Cell Reports
DOI 10.1016/j.celrep.2017.03.043
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.celrep.2017.03.043

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 12 references

Research works printed but not linked: 60

  1. Belgardt, 2010, CNS leptin and insulin action in the control of energy homeostasis, Ann. N Y Acad. Sci., 1212, 97, 10.1111/j.1749-6632.2010.05799.x · DOI
  2. Belgardt, 2009, Hormone and glucose signalling in POMC and AgRP neurons, J. Physiol., 587, 5305, 10.1113/jphysiol.2009.179192 · DOI
  3. Belgardt, 2010, Hypothalamic and pituitary c-Jun N-terminal kinase 1 signaling coordinately regulates glucose metabolism, Proc. Natl. Acad. Sci. USA, 107, 6028, 10.1073/pnas.1001796107 · DOI
  4. Benrick, 2009, Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei, J. Neuroendocrinol., 21, 620, 10.1111/j.1365-2826.2009.01879.x · DOI
  5. Burton, 2011, Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior, J. Neuroinflammation, 8, 54, 10.1186/1742-2094-8-54 · DOI
  6. Burton, 2013, Central inhibition of interleukin-6 trans-signaling during peripheral infection reduced neuroinflammation and sickness in aged mice, Brain Behav. Immun., 30, 66, 10.1016/j.bbi.2013.01.002 · DOI
  7. Campbell, 1993, Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6, Proc. Natl. Acad. Sci. USA, 90, 10061, 10.1073/pnas.90.21.10061 · DOI · Paper page
  8. Campbell, 2014, Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain, J. Neurosci., 34, 2503, 10.1523/JNEUROSCI.2830-13.2014 · DOI
  9. Carey, 2004, Interleukin-6 and tumor necrosis factor-alpha are not increased in patients with Type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness, Diabetologia, 47, 1029, 10.1007/s00125-004-1403-x · DOI
  10. Carey, 2006, Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase, Diabetes, 55, 2688, 10.2337/db05-1404 · DOI · Paper page
  11. Ellingsgaard, 2008, Interleukin-6 regulates pancreatic alpha-cell mass expansion, Proc. Natl. Acad. Sci. USA, 105, 13163, 10.1073/pnas.0801059105 · DOI · Paper page
  12. Ellingsgaard, 2011, Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells, Nat. Med., 17, 1481, 10.1038/nm.2513 · DOI · Paper page
  13. Ernst, 2009, Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity, J. Neurosci., 29, 11582, 10.1523/JNEUROSCI.5712-08.2009 · DOI · Paper page
  14. Fischer, 1997, I. A bioactive designer cytokine for human hematopoietic progenitor cell expansion, Nat. Biotechnol., 15, 142, 10.1038/nbt0297-142 · DOI
  15. Gruber, 2013, Obesity promotes liver carcinogenesis via Mcl-1 stabilization independent of IL-6Rα signaling, Cell Rep., 4, 669, 10.1016/j.celrep.2013.07.023 · DOI
  16. Hibi, 1990, Molecular cloning and expression of an IL-6 signal transducer, gp130, Cell, 63, 1149, 10.1016/0092-8674(90)90411-7 · DOI · Paper page
  17. Hill, 2010, Direct insulin and leptin action on pro-opiomelanocortin neurons is required for normal glucose homeostasis and fertility, Cell Metab., 11, 286, 10.1016/j.cmet.2010.03.002 · DOI · Paper page
  18. Hotamisligil, 2008, Inflammation and endoplasmic reticulum stress in obesity and diabetes, Int. J. Obes., 32, S52, 10.1038/ijo.2008.238 · DOI
  19. Hsu, 2015, Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M, Glia, 63, 132, 10.1002/glia.22739 · DOI
  20. Jones, 2011, Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling, J. Clin. Invest., 121, 3375, 10.1172/JCI57158 · DOI
  21. Jostock, 2001, Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses, Eur. J. Biochem., 268, 160, 10.1046/j.1432-1327.2001.01867.x · DOI
  22. Kim, 2012, Metformin ameliorates IL-6-induced hepatic insulin resistance via induction of orphan nuclear receptor small heterodimer partner (SHP) in mouse models, Diabetologia, 55, 1482, 10.1007/s00125-012-2494-4 · DOI
  23. Kleinridders, 2009, MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity, Cell Metab., 10, 249, 10.1016/j.cmet.2009.08.013 · DOI · Paper page
  24. Klöckener, 2011, High-fat feeding promotes obesity via insulin receptor/PI3K-dependent inhibition of SF-1 VMH neurons, Nat. Neurosci., 14, 911, 10.1038/nn.2847 · DOI
  25. Könner, 2012, Selective insulin and leptin resistance in metabolic disorders, Cell Metab., 16, 144, 10.1016/j.cmet.2012.07.004 · DOI
  26. Langhans, 2000, Anorexia of infection: current prospects, Nutrition, 16, 996, 10.1016/S0899-9007(00)00421-4 · DOI
  27. Li, 2002, Induction of uncoupling protein 1 by central interleukin-6 gene delivery is dependent on sympathetic innervation of brown adipose tissue and underlies one mechanism of body weight reduction in rats, Neuroscience, 115, 879, 10.1016/S0306-4522(02)00447-5 · DOI
  28. Lin, 2010, Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons, Diabetes, 59, 337, 10.2337/db09-1303 · DOI
  29. Liu, 2008, A technique for serial collection of cerebrospinal fluid from the cisterna magna in mouse, J. Vis. Exp., 10.3791/960 · DOI
  30. März, 1997, Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer’s disease patients, Neurosci. Lett., 239, 29, 10.1016/S0304-3940(97)00886-0 · DOI
  31. März, 1998, Sympathetic neurons can produce and respond to interleukin 6, Proc. Natl. Acad. Sci. USA, 95, 3251, 10.1073/pnas.95.6.3251 · DOI
  32. Mauer, 2014, Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin, Nat. Immunol., 15, 423, 10.1038/ni.2865 · DOI · Paper page
  33. Mauer, 2015, Versatile functions for IL-6 in metabolism and cancer, Trends Immunol., 36, 92, 10.1016/j.it.2014.12.008 · DOI
  34. Michalopoulou, 2004, Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases, Immunol. Lett., 94, 183, 10.1016/j.imlet.2004.04.018 · DOI
  35. Milanski, 2009, Saturated fatty acids produce an inflammatory response predominantly through the activation of TLR4 signaling in hypothalamus: implications for the pathogenesis of obesity, J. Neurosci., 29, 359, 10.1523/JNEUROSCI.2760-08.2009 · DOI · Paper page
  36. Mohamed-Ali, 1997, Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo, J. Clin. Endocrinol. Metab., 82, 4196
  37. Naitoh, 1988, Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats, Biochem. Biophys. Res. Commun., 155, 1459, 10.1016/S0006-291X(88)81305-6 · DOI · Paper page
  38. Narazaki, 1993, Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130, Blood, 82, 1120, 10.1182/blood.V82.4.1120.1120 · DOI · Paper page
  39. Navarra, 1991, Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway, Endocrinology, 128, 37, 10.1210/endo-128-1-37 · DOI
  40. Ostrowski, 1998, Evidence that interleukin-6 is produced in human skeletal muscle during prolonged running, J. Physiol., 508, 949, 10.1111/j.1469-7793.1998.949bp.x · DOI · Paper page
  41. Pedersen, 2008, Muscle as an endocrine organ: focus on muscle-derived interleukin-6, Physiol. Rev., 88, 1379, 10.1152/physrev.90100.2007 · DOI · Paper page
  42. Perello, 2013, Leptin activates oxytocin neurons of the hypothalamic paraventricular nucleus in both control and diet-induced obese rodents, PLoS ONE, 8, e59625, 10.1371/journal.pone.0059625 · DOI
  43. Plum, 2006, Central insulin action in energy and glucose homeostasis, J. Clin. Invest., 116, 1761, 10.1172/JCI29063 · DOI
  44. Plum, 2006, Enhanced PIP3 signaling in POMC neurons causes KATP channel activation and leads to diet-sensitive obesity, J. Clin. Invest., 116, 1886, 10.1172/JCI27123 · DOI
  45. Quintana, 2013, Astrocyte-specific deficiency of interleukin-6 and its receptor reveal specific roles in survival, body weight and behavior, Brain Behav. Immun., 27, 162, 10.1016/j.bbi.2012.10.011 · DOI
  46. Ropelle, 2010, IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKbeta and ER stress inhibition, PLoS Biol., 8, 10.1371/journal.pbio.1000465 · DOI
  47. Rose-John, 1994, Soluble receptors for cytokines and growth factors: generation and biological function, Biochem. J., 300, 281, 10.1042/bj3000281 · DOI
  48. Schéle, 2012, Interleukin-6 receptor α is co-localised with melanin-concentrating hormone in human and mouse hypothalamus, J. Neuroendocrinol., 24, 930, 10.1111/j.1365-2826.2012.02286.x · DOI
  49. Schéle, 2013, Inter-relation between interleukin (IL)-1, IL-6 and body fat regulating circuits of the hypothalamic arcuate nucleus, J. Neuroendocrinol., 25, 580, 10.1111/jne.12033 · DOI
  50. Steensberg, 2000, Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6, J. Physiol., 529, 237, 10.1111/j.1469-7793.2000.00237.x · DOI · Paper page
  51. Thaler, 2012, Obesity is associated with hypothalamic injury in rodents and humans, J. Clin. Invest., 122, 153, 10.1172/JCI59660 · DOI · Paper page
  52. Timper, 2016, Glucose-dependent insulinotropic peptide stimulates glucagon-like peptide 1 production by pancreatic islets via interleukin 6, produced by α cells, Gastroenterology, 151, 165, 10.1053/j.gastro.2016.03.003 · DOI · Paper page
  53. Tsaousidou, 2014, Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance, Cell Rep., 9, 1495, 10.1016/j.celrep.2014.10.045 · DOI
  54. Tsien, 1996, Subregion- and cell type-restricted gene knockout in mouse brain, Cell, 87, 1317, 10.1016/S0092-8674(00)81826-7 · DOI · Paper page
  55. Vogt, 2013, CNS insulin signaling in the control of energy homeostasis and glucose metabolism - from embryo to old age, Trends Endocrinol. Metab., 24, 76, 10.1016/j.tem.2012.11.004 · DOI
  56. Wallenius, 2002, Intracerebroventricular interleukin-6 treatment decreases body fat in rats, Biochem. Biophys. Res. Commun., 293, 560, 10.1016/S0006-291X(02)00230-9 · DOI
  57. Wallenius, 2002, Interleukin-6-deficient mice develop mature-onset obesity, Nat. Med., 8, 75, 10.1038/nm0102-75 · DOI · Paper page
  58. Wunderlich, 2012, Cutting edge: inhibition of IL-6 trans-signaling protects from malaria-induced lethality in mice, J. Immunol., 188, 4141, 10.4049/jimmunol.1102137 · DOI
  59. Xu, 2007, Inactivation of signal transducer and activator of transcription 3 in proopiomelanocortin (Pomc) neurons causes decreased pomc expression, mild obesity, and defects in compensatory refeeding, Endocrinology, 148, 72, 10.1210/en.2006-1119 · DOI
  60. Xu, 2008, Fate mapping Nkx2.1-lineage cells in the mouse telencephalon, J. Comp. Neurol., 506, 16, 10.1002/cne.21529 · DOI

Cited by

Sorted by citations

See all 233

Metadata

Authors
Timper, K., Denson, J. L., Steculorum, S. M., Heilinger, C., Engström-Ruud, L., Wunderlich, C. M., Rose-John, S., Wunderlich, F. T., & Brüning, J. C.
Venue
Cell Reports
Publisher
Elsevier BV
Published
2017-04
Volume
19
Issue
2
Pages
267-280
ISSN
2211-1247
DOI
10.1016/j.celrep.2017.03.043
Cited by
233
References
12
Language
en
Licence
Funders
  • Universität Basel
  • Seventh Framework Programme (266408)
  • Deutsche Forschungsgemeinschaft (BR 1492/7-1)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Helmholtz Association

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review